Calorie Restriction Retards the Aging Process
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Calorie restriction is the only experimental manipulation that prolongs longevity in experimental animals. The life prolonging effects of calorie restriction are related to a lower incidence of tumors and less inflammation, but more importantly, a lower generation of reactive oxygen species (ROS). This effect is related to the overexpression of two groups of enzymes. One is a group of (NAD+)‐dependent deacetylases called sirtuins whose main actions are to increase free fatty acid flow from adipose tissue, improve insulin secretion and promote mitochondrial biogenesis in muscle. The other group corresponds to uncoupling proteins (UCP), specially UCP 3 that reduces the mitochondrial production of ROS. On the other hand, an effect of calorie restriction that is always reported, is a decrease in resting energy expenditure. A reduction in the activity of UCP1 in brown adipose tissue could be a mechanisms to explain this effect. However sirtuins apparently increase the expression of UCP1.Recently PET CT scans have emerged as a non invasive methodology to recognize brown adipose tissue activity and indirectly, UCP1 activity. Also measurement of telomere length in peripheral blood mononuclear cells has consolidated as a good marker of aging. Two possible models of calorie restriction can be studied in humans. One is a retrospective model in which adults are separated in those that have maintained a stable weight during adulthood in a manner analogous to the weight clamp model of calorie restriction in non human primates. This model is only reliable if there are objective records of the weight that the studied subjects had 20 or more years ago. In the retrospective part of this project the investigators propose to study adults whose weight was recorded previously. The investigators pretend to compare telomere length and expression of SIRT1 and 6 in PBMC, plasma 8 isoprostanes and carotid intima media thickness between weight maintainers and weight gainers. The investigators hypothesis is that weight maintainers will have a better aging profile than weight gainers. In the prospective part of the project the investigators will study a human model of calorie restriction prescribing a 25% reduction in calorie intake during 3 months and comparing groups according to weight loss. At baseline and the end of the study period, UCP3 and SIRT1 expression in muscle biopsies, SIRT1 and 6 expression in PBMC and brown adipose activity, assessed by 18fluorodeoxyglucose uptake using PET/CT will measured. The investigators hypothesis is that individuals subjected to calorie restriction will experience an increase in the expression of UCP3, SIRT1 and SIRT6 and a reduction in brown adipose tissue activity. Simultaneously, these subjects will experience a reduction in oxidative stress markers in muscle and plasma.
| Condition | Intervention |
|---|---|
|
Obesity |
Behavioral: energy restricted mediterranean-type diet Behavioral: 25 % calorie restriction |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Basic Science |
| Official Title: | Calorie Restriction Retards the Aging Process by Inducing Sirtuins and Uncoupling Protein 3, Thereby Reducing the Production of Reactive Oxygen Species. |
- UCP3 mRNA expression in vastus lateralis after energy restriction [ Time Frame: 3 months ] [ Designated as safety issue: No ]The main outcome measure will be UCP3 mRNA expression in vastus lateralis, which will be measured before and after the 3 month intervention period. This enzyme is the last link in the chain of events that occur after calorie restriction. Millet et al reported a value for UCP3 mRNA of 15 ± 1.5 amol/ìg total RNA in 18 subjects. Expecting a 60% increase over baseline in the expression of the enzyme, 17 subjects per group are required to obtain results with an á of 0.05 and a power of 0.8. Considering attrition rates, we must study 24 subjects per group.
- Brown adipose tissue (BAT) activity, indicating UCP1 expression after calorie restriction [ Time Frame: 3 months ] [ Designated as safety issue: No ]Active BAT and its activation with cold exposure in humans, was demonstrated measuring 18 fluorodeoxyglucose uptake using PET‐CT and colocalized the areas of 18F‐FDG uptake to the expression of UCP1 thus for practical purposes it is a non invasive and reliable method to detect the presence of the tissue and the activity of UPC1, whic is downregulated by energy restriction.
| Estimated Enrollment: | 48 |
| Study Start Date: | May 2012 |
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Calorie restricted
25 % calorie restriction respect measured total energy expenditure, using a Mediterranean diet
|
Behavioral: energy restricted mediterranean-type diet
Prescription of diet 25 % lower than actual total energy expenditure in overweight or moderately obese premenopausal women
Other Names:
Behavioral: 25 % calorie restriction
25 % calorie restriction respect total energy expenditure
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 25 Years to 40 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- overweight or obese premenopausal women aged 25 - 40 years
Exclusion Criteria:
- diabetes,
- chronic diseases,
- extreme physical exercise,
- drugs affecting energy expenditure
Contacts and Locations| Contact: Maria Pia de la Maza, MD | 5629781502 | mpmaza@inta.uchile.cl |
| Contact: Daniel Carlos Bunout, MD | 5629781495 | dbunout@inta.uchile.cl |
| Chile | |
| Clinica Alemana de Santiago | Recruiting |
| Santiago, Region Metropolitana, Chile | |
| Contact: Pablo Lavados, MD plavados@alemana.cl | |
| Contact: Claudio Mizon, MD 56996321586 cmizon@alemana.cl | |
| Sub-Investigator: Claudio Mizon, MD | |
More Information
No publications provided
| Responsible Party: | MARIA PIA DE LA MAZA, MD, University of Chile |
| ClinicalTrials.gov Identifier: | NCT01508091 History of Changes |
| Other Study ID Numbers: | FONDECYT 1110035 |
| Study First Received: | January 6, 2012 |
| Last Updated: | October 20, 2012 |
| Health Authority: | Chile: Comisión Nacional de Investigación Científica y Tecnológica |
Keywords provided by University of Chile:
|
Obesity ageing |
Additional relevant MeSH terms:
|
Obesity Overnutrition Nutrition Disorders Overweight Body Weight Signs and Symptoms |
Mitochondrial uncoupling protein 3 Uncoupling Agents Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 16, 2013